Argentarii LLC Sells 39 Shares of HCA Healthcare, Inc. $HCA

Argentarii LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,485 shares of the company’s stock after selling 39 shares during the quarter. Argentarii LLC’s holdings in HCA Healthcare were worth $952,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Avantax Advisory Services Inc. boosted its position in HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock valued at $2,791,000 after acquiring an additional 32 shares in the last quarter. Glenview Trust co boosted its position in shares of HCA Healthcare by 2.3% in the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after purchasing an additional 32 shares in the last quarter. Horizon Investments LLC boosted its position in shares of HCA Healthcare by 1.1% in the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock worth $1,097,000 after purchasing an additional 33 shares in the last quarter. Sivia Capital Partners LLC boosted its position in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Finally, Catalyst Financial Partners LLC boosted its position in shares of HCA Healthcare by 4.3% in the 1st quarter. Catalyst Financial Partners LLC now owns 872 shares of the company’s stock worth $301,000 after purchasing an additional 36 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on HCA. Morgan Stanley lowered their price objective on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research report on Monday, July 28th. Robert W. Baird raised their target price on HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Bank of America raised their target price on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 10th. Stephens upgraded HCA Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Finally, Wells Fargo & Company reduced their target price on HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating for the company in a research note on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $407.75.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Trading Up 1.4%

HCA stock opened at $407.81 on Tuesday. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $420.98. The stock has a market cap of $95.42 billion, a price-to-earnings ratio of 17.14, a PEG ratio of 1.27 and a beta of 1.41. The business’s 50-day moving average is $385.76 and its 200 day moving average is $366.94.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. During the same period in the previous year, the firm posted $5.50 EPS. HCA Healthcare’s revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare’s payout ratio is currently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.